Cargando…

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study

BACKGROUND: Hypercortisolism is a recognized cause of non-alcoholic fatty liver disease (NAFLD). Mifepristone (Korlym®, Corcept Therapeutics), a glucocorticoid receptor (GR) antagonist, is FDA-approved for the treatment of hyperglycemia in patients with endogenous Cushing syndrome (CS). Mifepristone...

Descripción completa

Detalles Bibliográficos
Autores principales:	East, Honey E, Moraitis, Andreas G, Belanoff, Joseph K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627139/ http://dx.doi.org/10.1210/jendso/bvac150.1031

Ejemplares similares

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

PMON165 Favorable Liver Safety Profile of the Selective Glucocorticoid Receptor Modulator Relacorilant in Healthy and Hepatically Impaired Adults and in Patients with Cushing Syndrome
por: Moraitis, Andreas, et al.
Publicado: (2022)

ODP309 Ectopic Cushing's Syndrome: Importance of Methodical Approach to Hide and Seek
por: de Souza, Tamara G, et al.
Publicado: (2022)

ODP369 Weight Trajectory as a Predictor of Cushing's Disease
por: Thavaraputta, Subhanudh, et al.
Publicado: (2022)

ODP304 Cyclic Cushing Disease: A Diagnostic Challenge
por: Zubiran, Rafael, et al.
Publicado: (2022)

ODP303 Cushing's Syndrome Due to Ectopic Adrenocorticotropic Hormone-Secreting Metastatic Neuroendocrine Tumor
por: Cipriani, Allison, et al.
Publicado: (2022)

ODP340 NOVEL THERAPY OSILODROSTAT AS AN OPTION FOR RECURRENT CUSHING'S DISEASE
por: Marin, Luis Madera, et al.
Publicado: (2022)

MON-322 The Characteristic of Reproductive Disorders in Women with ACTH-Dependent Cushing Syndrome in the Republic of Uzbekistan (RUz) and Republic of Karakalpakstan (RKK)
por: Khalimova, Zamira Yusufovna, et al.
Publicado: (2020)

Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
por: Parker, John C., et al.
Publicado: (2021)

ODP603 Impact of CME at Improving Knowledge, Competence and Confidence Related to Management of Cushing Disease
por: Larkin, Amy, et al.
Publicado: (2022)

ODP302 Cushing's Disease: A Challenging Diagnosis in Patients with Underlying Co-Morbidities
por: Campbell, Spencer, et al.
Publicado: (2022)

SUN-451 A Randomized-Withdrawal, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Selective Glucocorticoid Receptor Antagonist, Relacorilant, in Patients with Cushing Syndrome (GRACE Study)
por: Auchus, Richard, et al.
Publicado: (2019)

ODP624 A case of Cushing disease demonstrated rapid deterioration of clinical findings and marked hypercortisolemia
por: Hashimoto, Makiko, et al.
Publicado: (2022)

ODP315 Hypoglycemia: Neuroendocrine Tumor of the Pancreas with Liver Metastasis and Transformation to Insulinoma
por: Ali, Basim, et al.
Publicado: (2022)

SUN-463 Tumor Shrinkage with Preoperative Relacorilant Therapy in Two Patients with Cushing Disease Due to Pituitary Macroadenomas
por: Terzolo, Massimo, et al.
Publicado: (2019)

THU021 Mysterious Resolution Of Cushing’s Disease
por: Whiteman, Daniel R, et al.
Publicado: (2023)

THU035 Impact Of Surgery Or Medical Treatment With The Selective Glucocorticoid Receptor Modulator Relacorilant On Hypercoagulopathy In Patients With Cushing Syndrome
por: Simeoli, Chiara, et al.
Publicado: (2023)

MON-413 First Reported Case of Combined High-Dose Mifepristone Therapy and Oral Contraceptive in Inducing Reversible Cholestatic Hepatitis in a Patient with Cushing Disease
por: Youssef, Nancy, et al.
Publicado: (2019)

ODP296 An unusual presentation of Glucagonoma syndrome.
por: Zare, Ahmad, et al.
Publicado: (2022)

ODP356 The Cortisol Conundrum: The Diagnostic Work up for Patients With Suspected Cushing's Disease and Hypercortisolaemia in Australia. Results of a Survey and Clinical Audit
por: Arulanantham, Jonathan, et al.
Publicado: (2022)

Resolution of Abnormal Gonadotropin Secretion After Surgical Cure in Men With ACTH-Dependent Cushing Syndrome
por: Shekhar, Skand, et al.
Publicado: (2021)

ODP349 Risk of Coronavirus Disease 2019 (COVID-19) in patients with Cushing's Disease (CD) is increased and independently associated with both obesity and disease activity
por: Mascarenhas Nakano, Bruna M, et al.
Publicado: (2022)

Hypercoagulability in ACTH-Dependent Cushing Syndrome
por: Singh Sumal, Amit Kartar, et al.
Publicado: (2021)

Occult Carcinoid Causes Cushing’s Syndrome
por: Meftali, Sabrina, et al.
Publicado: (2021)

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2023)

ODP308 Does This Patient Have Sheehan's Syndrome Due to Thrombosis?
por: Dawahir, Wafa, et al.
Publicado: (2022)

ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022)

PMON73 Lipid profile in patients with Cushing's syndrome and the impact of surgical treatment
por: Varghese, Ron, et al.
Publicado: (2022)

ODP314 Gynecomastia as the Initial Presentation of Acromegaly.
por: Lim, Frederick, et al.
Publicado: (2022)

ODP306 Diplopia as Presenting Manifestation of Acromegaly
por: Rjoob, Hani, et al.
Publicado: (2022)

ODP364 Prolactinomas in men: management challenges
por: Baciu, Ionela, et al.
Publicado: (2022)

MON-328 Disorders of Glucose Metabolism in Cushing Syndrome in Uzbekistan
por: Narimova, Gulchekhra Djumaniyazovna, et al.
Publicado: (2020)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

ODP365 The Psychological Impact of Adult-Onset Craniopharyngioma: The Experience of Patients and Clinicians
por: Daughters, Katie, et al.
Publicado: (2022)

SAT-263 A Vicious Cycle of Hypercortisolism - Cyclical Cushing’s Syndrome
por: Force, Bahar Kapoor, et al.
Publicado: (2020)

THU009 Subclinical Cushing’s Syndrome In An ACTH-secreting Pituitary Macroadenoma
por: Akabogu, Nwamaka Gloria, et al.
Publicado: (2023)

OR27-2 Growth Hormone Reduces Hepatic Steatosis, Inflammation and Fibrosis in Adults with Overweight/Obesity and Nonalcoholic Fatty Liver Disease
por: Bartsch, Lea, et al.
Publicado: (2022)

SAT-256 The Ever Confusing Cushing’s Work Up: Is It Real? Is It Pseudo Cushing’s’? Or Could It Be Factitious
por: Ghalib, Luma, et al.
Publicado: (2020)

SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
por: Warachit, Wasita, et al.
Publicado: (2020)

PMON87 A Case of Mineralocorticoid Induced Hypertension Secondary to Cushing's Syndrome
por: Abideen, Zain U, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dcl2dn8nfk67nsfpto271363n6